TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CDXS

Codexis Inc

Healthcare · Biotechnology

1.30$ -3.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CDXS
Line item 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +143.3% -37.6% +39.7% +42.7% -3.8% -26.5% -41.1% -18.2% -7.2% -20.2% +50.4% +46.0% +90.4% +48.7% +11.2% +1.6% -45.5% +9.1% -0.8%
– +154.7% -48.2% +39.4% +36.8% -14.1% -24.6% -40.1% -7.8% -0.5% -17.1% +65.4% +49.2% +70.0% +61.5% -12.2% +0.6% -42.6% +5.7% -2.0%
– +70.8% -60.2% +45.1% +127.8% -64.4% +24.2% -30.9% +19.7% -12.1% -17.3% +62.3% +69.9% +70.6% +64.8% -21.7% -2.4% -42.9% -70.4% +163.7%
– +160.7% -55.8% +49.6% +30.3% -26.1% -14.9% -44.8% +5.4% -12.1% -17.3% +62.3% +69.9% +70.6% +65.9% -22.2% -2.4% -42.9% +12.8% +6.5%
– +133.6% -3.7% +17.0% +111.6% +23.4% -60.1% -28.3% -28.5% +89.4% -19.2% +99.2% +5.9% +61.2% +45.3% +28.6% +8.6% -51.2% -5.2% -43.2%
– +68.6% +82.0% -2.0% -3.4% +59.3% -71.0% +14.2% -6.2% -28.9% -16.8% +25.6% -43.1% -37.0% +159.8% +20.3% +74.9% +32.3% -33.0% +1.0%
– – – +34.8% -0.6% +12.7% -31.1% -49.3% -52.7% -22.2% -30.7% +30.6% +69.1% +32.0% +54.0% +576.6% -5.5% – – –
– +60.9% +1.2% +3.3% +0.0% +0.0% +0.0% +0.0% +0.0% +0.0% +0.0% +0.0% +0.0% +0.0% +0.0% +0.0% +0.0% -24.0% +0.0% +0.0%
– +19.8% -35.6% -48.2% +2,072.2% -18.4% -21.3% -26.1% -35.3% -54.5% +15.3% +0.0% – – – – – – – –
– +102.2% -0.5% -68.9% -45.4% -2.1% -35.2% -19.4% +25.7% -0.2% -24.0% +75.7% -24.4% +98.2% +18.3% +59.1% +28.8% -52.7% +64.3% +18.5%
– +150.0% +24.1% +15.5% -43.9% +2.9% -42.4% -31.2% +22.6% +8.1% -16.7% +101.8% -31.4% -10.1% +62.3% +33.6% +47.0% -27.0% -34.0% +7.1%
– +188.9% +15.2% +3.4% – – – – – – +0.0% +0.0% +0.0% +174.6% +125.1% +55.8% +31.0% -29.5% -25.2% +4.1%
– +69.6% +116.9% +9.1% -7.9% +12.6% -64.7% +8.4% +18.0% -27.3% +24.5% -16.2% -14.0% -14.1% +13.3% +0.8% +8.4% +83.2% -52.3% -45.2%
– – – -69.7% – – – – – – – – – – – – – – – +38.7%
– – – – +2.4% -4.4% -23.6% -47.1% -36.6% -13.0% -16.5% +28.5% +129.4% +87.4% +61.2% -3.4% -11.9% -40.2% -22.7% -24.5%
– – – – – – – – – – – – – – – – – – – –
– +0.0% +0.0% -3.4% +838.0% +45.1% +3.1% +4.0% -0.1% +3.2% +3.0% +13.8% +12.9% +8.3% +5.0% +8.8% +1.2% +4.3% +7.7% +18.7%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?